nodes	percent_of_prediction	percent_of_DWPC	metapath
Selegiline—CYP2E1—Fingolimod—multiple sclerosis	0.0993	0.145	CbGbCtD
Selegiline—CYP2A6—Prednisolone—multiple sclerosis	0.0622	0.091	CbGbCtD
Selegiline—CYP2D6—Fingolimod—multiple sclerosis	0.0473	0.0692	CbGbCtD
Selegiline—CYP2E1—Mitoxantrone—multiple sclerosis	0.0467	0.0683	CbGbCtD
Selegiline—CYP2A6—Dexamethasone—multiple sclerosis	0.0367	0.0536	CbGbCtD
Selegiline—ABCB1—Methylprednisolone—multiple sclerosis	0.0323	0.0473	CbGbCtD
Selegiline—CYP3A4—Fingolimod—multiple sclerosis	0.0301	0.044	CbGbCtD
Selegiline—CYP2C19—Prednisone—multiple sclerosis	0.0243	0.0355	CbGbCtD
Selegiline—CYP2E1—Dexamethasone—multiple sclerosis	0.0242	0.0354	CbGbCtD
Selegiline—CYP2B6—Dexamethasone—multiple sclerosis	0.0239	0.0349	CbGbCtD
Selegiline—ABCB1—Mitoxantrone—multiple sclerosis	0.0236	0.0345	CbGbCtD
Selegiline—ABCB1—Betamethasone—multiple sclerosis	0.021	0.0308	CbGbCtD
Selegiline—ABCB1—Prednisolone—multiple sclerosis	0.0208	0.0304	CbGbCtD
Selegiline—ABCB1—Prednisone—multiple sclerosis	0.0196	0.0287	CbGbCtD
Selegiline—CYP3A4—Methylprednisolone—multiple sclerosis	0.0194	0.0284	CbGbCtD
Selegiline—CYP2C8—Dexamethasone—multiple sclerosis	0.0181	0.0264	CbGbCtD
Selegiline—CYP2C19—Dexamethasone—multiple sclerosis	0.0152	0.0222	CbGbCtD
Selegiline—CYP3A4—Triamcinolone—multiple sclerosis	0.0147	0.0215	CbGbCtD
Selegiline—CYP3A4—Mitoxantrone—multiple sclerosis	0.0141	0.0207	CbGbCtD
Selegiline—CYP2C9—Dexamethasone—multiple sclerosis	0.0126	0.0184	CbGbCtD
Selegiline—CYP3A4—Betamethasone—multiple sclerosis	0.0126	0.0184	CbGbCtD
Selegiline—CYP3A4—Prednisolone—multiple sclerosis	0.0124	0.0182	CbGbCtD
Selegiline—ABCB1—Dexamethasone—multiple sclerosis	0.0122	0.0179	CbGbCtD
Selegiline—CYP3A4—Prednisone—multiple sclerosis	0.0117	0.0172	CbGbCtD
Selegiline—CYP2D6—Dexamethasone—multiple sclerosis	0.0115	0.0169	CbGbCtD
Selegiline—ABCB1—Methotrexate—multiple sclerosis	0.00983	0.0144	CbGbCtD
Selegiline—CYP3A4—Dexamethasone—multiple sclerosis	0.00733	0.0107	CbGbCtD
Selegiline—Pseudoephedrine—IL2—multiple sclerosis	0.00165	0.557	CrCbGaD
Selegiline—Ephedrine—BCHE—multiple sclerosis	0.000758	0.256	CrCbGaD
Selegiline—Pseudoephedrine—TNF—multiple sclerosis	0.000558	0.188	CrCbGaD
Selegiline—MAOB—nerve—multiple sclerosis	0.000397	0.103	CbGeAlD
Selegiline—MAOA—nerve—multiple sclerosis	0.000339	0.0882	CbGeAlD
Selegiline—MAOB—brainstem—multiple sclerosis	0.00017	0.0444	CbGeAlD
Selegiline—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000156	0.00314	CbGpPWpGaD
Selegiline—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000156	0.00314	CbGpPWpGaD
Selegiline—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000154	0.0031	CbGpPWpGaD
Selegiline—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000154	0.0031	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	0.000153	0.00308	CbGpPWpGaD
Selegiline—MAOA—brainstem—multiple sclerosis	0.000145	0.0379	CbGeAlD
Selegiline—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000141	0.00285	CbGpPWpGaD
Selegiline—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000141	0.00285	CbGpPWpGaD
Selegiline—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000141	0.00285	CbGpPWpGaD
Selegiline—MAOA—retina—multiple sclerosis	0.00014	0.0365	CbGeAlD
Selegiline—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000139	0.00281	CbGpPWpGaD
Selegiline—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000139	0.00281	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	0.000139	0.00279	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000138	0.00277	CbGpPWpGaD
Selegiline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000132	0.00265	CbGpPWpGaD
Selegiline—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.00013	0.00262	CbGpPWpGaD
Selegiline—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.00013	0.00262	CbGpPWpGaD
Selegiline—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000129	0.00259	CbGpPWpGaD
Selegiline—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000129	0.00259	CbGpPWpGaD
Selegiline—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000128	0.00258	CbGpPWpGaD
Selegiline—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000128	0.00258	CbGpPWpGaD
Selegiline—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000127	0.00256	CbGpPWpGaD
Selegiline—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000127	0.00256	CbGpPWpGaD
Selegiline—MAOA—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000127	0.00255	CbGpPWpGaD
Selegiline—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000122	0.00245	CbGpPWpGaD
Selegiline—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000121	0.00244	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	0.00012	0.00242	CbGpPWpGaD
Selegiline—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.00012	0.00241	CbGpPWpGaD
Selegiline—MAOB—medulla oblongata—multiple sclerosis	0.000119	0.031	CbGeAlD
Selegiline—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.000117	0.00235	CbGpPWpGaD
Selegiline—MAOB—Metabolism—SRM—multiple sclerosis	0.000116	0.00233	CbGpPWpGaD
Selegiline—Alopecia—Prednisone—multiple sclerosis	0.000116	0.000445	CcSEcCtD
Selegiline—Shock—Methylprednisolone—multiple sclerosis	0.000115	0.000444	CcSEcCtD
Selegiline—MAOA—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000115	0.00232	CbGpPWpGaD
Selegiline—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000115	0.000443	CcSEcCtD
Selegiline—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000115	0.000443	CcSEcCtD
Selegiline—Loss of consciousness—Betamethasone—multiple sclerosis	0.000115	0.000442	CcSEcCtD
Selegiline—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000115	0.000442	CcSEcCtD
Selegiline—Epistaxis—Methotrexate—multiple sclerosis	0.000115	0.000442	CcSEcCtD
Selegiline—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000115	0.000442	CcSEcCtD
Selegiline—Paraesthesia—Prednisolone—multiple sclerosis	0.000115	0.000442	CcSEcCtD
Selegiline—Tachycardia—Triamcinolone—multiple sclerosis	0.000115	0.000442	CcSEcCtD
Selegiline—Mental disorder—Prednisone—multiple sclerosis	0.000115	0.000441	CcSEcCtD
Selegiline—Nausea—Azathioprine—multiple sclerosis	0.000115	0.000441	CcSEcCtD
Selegiline—Tachycardia—Methylprednisolone—multiple sclerosis	0.000114	0.000441	CcSEcCtD
Selegiline—Skin disorder—Methylprednisolone—multiple sclerosis	0.000114	0.000438	CcSEcCtD
Selegiline—Malnutrition—Prednisone—multiple sclerosis	0.000114	0.000438	CcSEcCtD
Selegiline—Erythema—Prednisone—multiple sclerosis	0.000114	0.000438	CcSEcCtD
Selegiline—CYP2A6—cerebellum—multiple sclerosis	0.000114	0.0297	CbGeAlD
Selegiline—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000114	0.000437	CcSEcCtD
Selegiline—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000113	0.000436	CcSEcCtD
Selegiline—Convulsion—Dexamethasone—multiple sclerosis	0.000113	0.000436	CcSEcCtD
Selegiline—Convulsion—Betamethasone—multiple sclerosis	0.000113	0.000436	CcSEcCtD
Selegiline—Hypertension—Dexamethasone—multiple sclerosis	0.000113	0.000434	CcSEcCtD
Selegiline—Hypertension—Betamethasone—multiple sclerosis	0.000113	0.000434	CcSEcCtD
Selegiline—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	0.000112	0.00225	CbGpPWpGaD
Selegiline—Asthenia—Mitoxantrone—multiple sclerosis	0.000112	0.00043	CcSEcCtD
Selegiline—Myalgia—Dexamethasone—multiple sclerosis	0.000111	0.000428	CcSEcCtD
Selegiline—Myalgia—Betamethasone—multiple sclerosis	0.000111	0.000428	CcSEcCtD
Selegiline—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.000111	0.00223	CbGpPWpGaD
Selegiline—Anxiety—Betamethasone—multiple sclerosis	0.000111	0.000427	CcSEcCtD
Selegiline—Anxiety—Dexamethasone—multiple sclerosis	0.000111	0.000427	CcSEcCtD
Selegiline—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.00011	0.00222	CbGpPWpGaD
Selegiline—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.00011	0.00222	CbGpPWpGaD
Selegiline—Discomfort—Betamethasone—multiple sclerosis	0.00011	0.000423	CcSEcCtD
Selegiline—Discomfort—Dexamethasone—multiple sclerosis	0.00011	0.000423	CcSEcCtD
Selegiline—Hypotension—Methylprednisolone—multiple sclerosis	0.00011	0.000422	CcSEcCtD
Selegiline—Pain—Prednisolone—multiple sclerosis	0.000109	0.000421	CcSEcCtD
Selegiline—Hepatitis—Methotrexate—multiple sclerosis	0.000109	0.000421	CcSEcCtD
Selegiline—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000109	0.00219	CbGpPWpGaD
Selegiline—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000109	0.00219	CbGpPWpGaD
Selegiline—MAOB—midbrain—multiple sclerosis	0.000109	0.0283	CbGeAlD
Selegiline—Pharyngitis—Methotrexate—multiple sclerosis	0.000108	0.000417	CcSEcCtD
Selegiline—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000108	0.000415	CcSEcCtD
Selegiline—MAOA—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000108	0.00217	CbGpPWpGaD
Selegiline—Vision blurred—Prednisone—multiple sclerosis	0.000107	0.000413	CcSEcCtD
Selegiline—Urethral disorder—Methotrexate—multiple sclerosis	0.000107	0.000412	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000107	0.000412	CcSEcCtD
Selegiline—MAOB—Biological oxidations—POMC—multiple sclerosis	0.000107	0.00215	CbGpPWpGaD
Selegiline—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000107	0.000411	CcSEcCtD
Selegiline—ABCB1—Allograft Rejection—CD40—multiple sclerosis	0.000107	0.00215	CbGpPWpGaD
Selegiline—Oedema—Betamethasone—multiple sclerosis	0.000107	0.000411	CcSEcCtD
Selegiline—Oedema—Dexamethasone—multiple sclerosis	0.000107	0.000411	CcSEcCtD
Selegiline—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000107	0.00041	CcSEcCtD
Selegiline—Insomnia—Triamcinolone—multiple sclerosis	0.000106	0.000409	CcSEcCtD
Selegiline—Insomnia—Methylprednisolone—multiple sclerosis	0.000106	0.000408	CcSEcCtD
Selegiline—Infection—Betamethasone—multiple sclerosis	0.000106	0.000408	CcSEcCtD
Selegiline—Infection—Dexamethasone—multiple sclerosis	0.000106	0.000408	CcSEcCtD
Selegiline—MAOB—spinal cord—multiple sclerosis	0.000106	0.0276	CbGeAlD
Selegiline—Ill-defined disorder—Prednisone—multiple sclerosis	0.000106	0.000406	CcSEcCtD
Selegiline—Paraesthesia—Triamcinolone—multiple sclerosis	0.000106	0.000406	CcSEcCtD
Selegiline—Feeling abnormal—Prednisolone—multiple sclerosis	0.000105	0.000405	CcSEcCtD
Selegiline—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000105	0.000405	CcSEcCtD
Selegiline—Visual impairment—Methotrexate—multiple sclerosis	0.000105	0.000405	CcSEcCtD
Selegiline—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	0.000105	0.00212	CbGpPWpGaD
Selegiline—Anaemia—Prednisone—multiple sclerosis	0.000105	0.000405	CcSEcCtD
Selegiline—Shock—Dexamethasone—multiple sclerosis	0.000105	0.000404	CcSEcCtD
Selegiline—Shock—Betamethasone—multiple sclerosis	0.000105	0.000404	CcSEcCtD
Selegiline—Dyspnoea—Triamcinolone—multiple sclerosis	0.000105	0.000403	CcSEcCtD
Selegiline—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000105	0.000403	CcSEcCtD
Selegiline—Nervous system disorder—Betamethasone—multiple sclerosis	0.000105	0.000403	CcSEcCtD
Selegiline—Agitation—Prednisone—multiple sclerosis	0.000105	0.000403	CcSEcCtD
Selegiline—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000104	0.000402	CcSEcCtD
Selegiline—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000104	0.000402	CcSEcCtD
Selegiline—Tachycardia—Betamethasone—multiple sclerosis	0.000104	0.000401	CcSEcCtD
Selegiline—Tachycardia—Dexamethasone—multiple sclerosis	0.000104	0.000401	CcSEcCtD
Selegiline—Dyspepsia—Triamcinolone—multiple sclerosis	0.000103	0.000398	CcSEcCtD
Selegiline—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000103	0.000397	CcSEcCtD
Selegiline—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000103	0.000397	CcSEcCtD
Selegiline—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000103	0.000397	CcSEcCtD
Selegiline—MAOA—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000103	0.00207	CbGpPWpGaD
Selegiline—Malaise—Prednisone—multiple sclerosis	0.000103	0.000395	CcSEcCtD
Selegiline—Vertigo—Prednisone—multiple sclerosis	0.000102	0.000394	CcSEcCtD
Selegiline—Syncope—Prednisone—multiple sclerosis	0.000102	0.000393	CcSEcCtD
Selegiline—Tinnitus—Methotrexate—multiple sclerosis	0.000102	0.000392	CcSEcCtD
Selegiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000102	0.00205	CbGpPWpGaD
Selegiline—Anorexia—Betamethasone—multiple sclerosis	0.000102	0.000391	CcSEcCtD
Selegiline—Anorexia—Dexamethasone—multiple sclerosis	0.000102	0.000391	CcSEcCtD
Selegiline—Urticaria—Prednisolone—multiple sclerosis	0.000102	0.000391	CcSEcCtD
Selegiline—Fatigue—Triamcinolone—multiple sclerosis	0.000101	0.00039	CcSEcCtD
Selegiline—MAOA—medulla oblongata—multiple sclerosis	0.000101	0.0264	CbGeAlD
Selegiline—Fatigue—Methylprednisolone—multiple sclerosis	0.000101	0.000389	CcSEcCtD
Selegiline—Pain—Triamcinolone—multiple sclerosis	0.000101	0.000387	CcSEcCtD
Selegiline—Loss of consciousness—Prednisone—multiple sclerosis	0.0001	0.000385	CcSEcCtD
Selegiline—Hypotension—Dexamethasone—multiple sclerosis	9.97e-05	0.000384	CcSEcCtD
Selegiline—Hypotension—Betamethasone—multiple sclerosis	9.97e-05	0.000384	CcSEcCtD
Selegiline—Angiopathy—Methotrexate—multiple sclerosis	9.92e-05	0.000382	CcSEcCtD
Selegiline—Vomiting—Mitoxantrone—multiple sclerosis	9.91e-05	0.000381	CcSEcCtD
Selegiline—Convulsion—Prednisone—multiple sclerosis	9.86e-05	0.00038	CcSEcCtD
Selegiline—Hypertension—Prednisone—multiple sclerosis	9.83e-05	0.000378	CcSEcCtD
Selegiline—Rash—Mitoxantrone—multiple sclerosis	9.83e-05	0.000378	CcSEcCtD
Selegiline—CYP2A6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.82e-05	0.00198	CbGpPWpGaD
Selegiline—Dermatitis—Mitoxantrone—multiple sclerosis	9.82e-05	0.000378	CcSEcCtD
Selegiline—Chills—Methotrexate—multiple sclerosis	9.81e-05	0.000377	CcSEcCtD
Selegiline—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.77e-05	0.00197	CbGpPWpGaD
Selegiline—Headache—Mitoxantrone—multiple sclerosis	9.76e-05	0.000376	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	9.72e-05	0.000374	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	9.72e-05	0.000374	CcSEcCtD
Selegiline—Myalgia—Prednisone—multiple sclerosis	9.69e-05	0.000373	CcSEcCtD
Selegiline—Arthralgia—Prednisone—multiple sclerosis	9.69e-05	0.000373	CcSEcCtD
Selegiline—Feeling abnormal—Triamcinolone—multiple sclerosis	9.69e-05	0.000373	CcSEcCtD
Selegiline—Feeling abnormal—Methylprednisolone—multiple sclerosis	9.67e-05	0.000372	CcSEcCtD
Selegiline—Anxiety—Prednisone—multiple sclerosis	9.66e-05	0.000372	CcSEcCtD
Selegiline—Alopecia—Methotrexate—multiple sclerosis	9.66e-05	0.000372	CcSEcCtD
Selegiline—Insomnia—Betamethasone—multiple sclerosis	9.65e-05	0.000371	CcSEcCtD
Selegiline—Insomnia—Dexamethasone—multiple sclerosis	9.65e-05	0.000371	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	9.62e-05	0.00037	CcSEcCtD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	9.62e-05	0.00194	CbGpPWpGaD
Selegiline—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	9.59e-05	0.000369	CcSEcCtD
Selegiline—Paraesthesia—Betamethasone—multiple sclerosis	9.58e-05	0.000369	CcSEcCtD
Selegiline—Paraesthesia—Dexamethasone—multiple sclerosis	9.58e-05	0.000369	CcSEcCtD
Selegiline—Discomfort—Prednisone—multiple sclerosis	9.58e-05	0.000368	CcSEcCtD
Selegiline—Mental disorder—Methotrexate—multiple sclerosis	9.57e-05	0.000368	CcSEcCtD
Selegiline—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.57e-05	0.00193	CbGpPWpGaD
Selegiline—Malnutrition—Methotrexate—multiple sclerosis	9.51e-05	0.000366	CcSEcCtD
Selegiline—Erythema—Methotrexate—multiple sclerosis	9.51e-05	0.000366	CcSEcCtD
Selegiline—Hypersensitivity—Prednisolone—multiple sclerosis	9.42e-05	0.000362	CcSEcCtD
Selegiline—Dyspepsia—Dexamethasone—multiple sclerosis	9.39e-05	0.000361	CcSEcCtD
Selegiline—Dyspepsia—Betamethasone—multiple sclerosis	9.39e-05	0.000361	CcSEcCtD
Selegiline—Urticaria—Triamcinolone—multiple sclerosis	9.34e-05	0.000359	CcSEcCtD
Selegiline—Urticaria—Methylprednisolone—multiple sclerosis	9.32e-05	0.000359	CcSEcCtD
Selegiline—Dysgeusia—Methotrexate—multiple sclerosis	9.32e-05	0.000358	CcSEcCtD
Selegiline—Body temperature increased—Triamcinolone—multiple sclerosis	9.29e-05	0.000358	CcSEcCtD
Selegiline—Oedema—Prednisone—multiple sclerosis	9.29e-05	0.000358	CcSEcCtD
Selegiline—Abdominal pain—Methylprednisolone—multiple sclerosis	9.27e-05	0.000357	CcSEcCtD
Selegiline—Decreased appetite—Betamethasone—multiple sclerosis	9.27e-05	0.000357	CcSEcCtD
Selegiline—Decreased appetite—Dexamethasone—multiple sclerosis	9.27e-05	0.000357	CcSEcCtD
Selegiline—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	9.27e-05	0.00186	CbGpPWpGaD
Selegiline—MAOA—midbrain—multiple sclerosis	9.26e-05	0.0241	CbGeAlD
Selegiline—Nausea—Mitoxantrone—multiple sclerosis	9.26e-05	0.000356	CcSEcCtD
Selegiline—CYP2A6—brain—multiple sclerosis	9.24e-05	0.0241	CbGeAlD
Selegiline—Infection—Prednisone—multiple sclerosis	9.23e-05	0.000355	CcSEcCtD
Selegiline—Gastrointestinal disorder—Betamethasone—multiple sclerosis	9.21e-05	0.000354	CcSEcCtD
Selegiline—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	9.21e-05	0.000354	CcSEcCtD
Selegiline—Back pain—Methotrexate—multiple sclerosis	9.2e-05	0.000354	CcSEcCtD
Selegiline—Fatigue—Dexamethasone—multiple sclerosis	9.2e-05	0.000354	CcSEcCtD
Selegiline—Fatigue—Betamethasone—multiple sclerosis	9.2e-05	0.000354	CcSEcCtD
Selegiline—Shock—Prednisone—multiple sclerosis	9.14e-05	0.000352	CcSEcCtD
Selegiline—Pain—Betamethasone—multiple sclerosis	9.12e-05	0.000351	CcSEcCtD
Selegiline—Pain—Dexamethasone—multiple sclerosis	9.12e-05	0.000351	CcSEcCtD
Selegiline—Nervous system disorder—Prednisone—multiple sclerosis	9.11e-05	0.000351	CcSEcCtD
Selegiline—Tachycardia—Prednisone—multiple sclerosis	9.07e-05	0.000349	CcSEcCtD
Selegiline—MAOA—spinal cord—multiple sclerosis	9.04e-05	0.0236	CbGeAlD
Selegiline—Skin disorder—Prednisone—multiple sclerosis	9.02e-05	0.000347	CcSEcCtD
Selegiline—Hyperhidrosis—Prednisone—multiple sclerosis	8.98e-05	0.000346	CcSEcCtD
Selegiline—Vision blurred—Methotrexate—multiple sclerosis	8.97e-05	0.000345	CcSEcCtD
Selegiline—MAOB—nervous system—multiple sclerosis	8.92e-05	0.0233	CbGeAlD
Selegiline—Anorexia—Prednisone—multiple sclerosis	8.86e-05	0.000341	CcSEcCtD
Selegiline—MAOA—Neuronal System—BCHE—multiple sclerosis	8.83e-05	0.00178	CbGpPWpGaD
Selegiline—Ill-defined disorder—Methotrexate—multiple sclerosis	8.83e-05	0.00034	CcSEcCtD
Selegiline—Anaemia—Methotrexate—multiple sclerosis	8.79e-05	0.000338	CcSEcCtD
Selegiline—Feeling abnormal—Dexamethasone—multiple sclerosis	8.79e-05	0.000338	CcSEcCtD
Selegiline—Feeling abnormal—Betamethasone—multiple sclerosis	8.79e-05	0.000338	CcSEcCtD
Selegiline—Gastrointestinal pain—Dexamethasone—multiple sclerosis	8.72e-05	0.000336	CcSEcCtD
Selegiline—Gastrointestinal pain—Betamethasone—multiple sclerosis	8.72e-05	0.000336	CcSEcCtD
Selegiline—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	8.67e-05	0.00174	CbGpPWpGaD
Selegiline—Hypersensitivity—Triamcinolone—multiple sclerosis	8.66e-05	0.000333	CcSEcCtD
Selegiline—Hypersensitivity—Methylprednisolone—multiple sclerosis	8.64e-05	0.000333	CcSEcCtD
Selegiline—CYP2D6—brainstem—multiple sclerosis	8.64e-05	0.0225	CbGeAlD
Selegiline—MAOB—central nervous system—multiple sclerosis	8.59e-05	0.0224	CbGeAlD
Selegiline—Malaise—Methotrexate—multiple sclerosis	8.58e-05	0.00033	CcSEcCtD
Selegiline—Vertigo—Methotrexate—multiple sclerosis	8.55e-05	0.000329	CcSEcCtD
Selegiline—Leukopenia—Methotrexate—multiple sclerosis	8.52e-05	0.000328	CcSEcCtD
Selegiline—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	8.5e-05	0.00171	CbGpPWpGaD
Selegiline—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	8.5e-05	0.00171	CbGpPWpGaD
Selegiline—Urticaria—Dexamethasone—multiple sclerosis	8.47e-05	0.000326	CcSEcCtD
Selegiline—Urticaria—Betamethasone—multiple sclerosis	8.47e-05	0.000326	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Prednisone—multiple sclerosis	8.46e-05	0.000326	CcSEcCtD
Selegiline—Dizziness—Prednisolone—multiple sclerosis	8.45e-05	0.000325	CcSEcCtD
Selegiline—Asthenia—Triamcinolone—multiple sclerosis	8.44e-05	0.000325	CcSEcCtD
Selegiline—Abdominal pain—Dexamethasone—multiple sclerosis	8.43e-05	0.000325	CcSEcCtD
Selegiline—Body temperature increased—Betamethasone—multiple sclerosis	8.43e-05	0.000325	CcSEcCtD
Selegiline—Abdominal pain—Betamethasone—multiple sclerosis	8.43e-05	0.000325	CcSEcCtD
Selegiline—Body temperature increased—Dexamethasone—multiple sclerosis	8.43e-05	0.000325	CcSEcCtD
Selegiline—Asthenia—Methylprednisolone—multiple sclerosis	8.42e-05	0.000324	CcSEcCtD
Selegiline—Insomnia—Prednisone—multiple sclerosis	8.4e-05	0.000323	CcSEcCtD
Selegiline—MAOB—cerebellum—multiple sclerosis	8.4e-05	0.0219	CbGeAlD
Selegiline—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	8.39e-05	0.00169	CbGpPWpGaD
Selegiline—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	8.39e-05	0.00169	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—CD86—multiple sclerosis	8.35e-05	0.00168	CbGpPWpGaD
Selegiline—Paraesthesia—Prednisone—multiple sclerosis	8.34e-05	0.000321	CcSEcCtD
Selegiline—Pruritus—Triamcinolone—multiple sclerosis	8.32e-05	0.00032	CcSEcCtD
Selegiline—Cough—Methotrexate—multiple sclerosis	8.3e-05	0.000319	CcSEcCtD
Selegiline—Pruritus—Methylprednisolone—multiple sclerosis	8.3e-05	0.000319	CcSEcCtD
Selegiline—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.28e-05	0.00167	CbGpPWpGaD
Selegiline—Convulsion—Methotrexate—multiple sclerosis	8.24e-05	0.000317	CcSEcCtD
Selegiline—ABCB1—Allograft Rejection—IL10—multiple sclerosis	8.18e-05	0.00165	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	8.18e-05	0.00165	CbGpPWpGaD
Selegiline—Dyspepsia—Prednisone—multiple sclerosis	8.18e-05	0.000315	CcSEcCtD
Selegiline—MAOB—Metabolism—CYP27B1—multiple sclerosis	8.14e-05	0.00164	CbGpPWpGaD
Selegiline—MAOB—Metabolism—CYP24A1—multiple sclerosis	8.14e-05	0.00164	CbGpPWpGaD
Selegiline—Arthralgia—Methotrexate—multiple sclerosis	8.1e-05	0.000312	CcSEcCtD
Selegiline—Chest pain—Methotrexate—multiple sclerosis	8.1e-05	0.000312	CcSEcCtD
Selegiline—Myalgia—Methotrexate—multiple sclerosis	8.1e-05	0.000312	CcSEcCtD
Selegiline—Decreased appetite—Prednisone—multiple sclerosis	8.08e-05	0.000311	CcSEcCtD
Selegiline—Rash—Prednisolone—multiple sclerosis	8.06e-05	0.00031	CcSEcCtD
Selegiline—Dermatitis—Prednisolone—multiple sclerosis	8.05e-05	0.00031	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	8.04e-05	0.00031	CcSEcCtD
Selegiline—Diarrhoea—Methylprednisolone—multiple sclerosis	8.03e-05	0.000309	CcSEcCtD
Selegiline—Fatigue—Prednisone—multiple sclerosis	8.01e-05	0.000308	CcSEcCtD
Selegiline—Headache—Prednisolone—multiple sclerosis	8.01e-05	0.000308	CcSEcCtD
Selegiline—Discomfort—Methotrexate—multiple sclerosis	8e-05	0.000308	CcSEcCtD
Selegiline—ABCB1—Allograft Rejection—IL4—multiple sclerosis	7.96e-05	0.0016	CbGpPWpGaD
Selegiline—Constipation—Prednisone—multiple sclerosis	7.94e-05	0.000306	CcSEcCtD
Selegiline—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.92e-05	0.00159	CbGpPWpGaD
Selegiline—Confusional state—Methotrexate—multiple sclerosis	7.83e-05	0.000301	CcSEcCtD
Selegiline—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	7.79e-05	0.00157	CbGpPWpGaD
Selegiline—Dizziness—Triamcinolone—multiple sclerosis	7.77e-05	0.000299	CcSEcCtD
Selegiline—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.76e-05	0.00156	CbGpPWpGaD
Selegiline—Dizziness—Methylprednisolone—multiple sclerosis	7.76e-05	0.000299	CcSEcCtD
Selegiline—Infection—Methotrexate—multiple sclerosis	7.71e-05	0.000297	CcSEcCtD
Selegiline—Feeling abnormal—Prednisone—multiple sclerosis	7.66e-05	0.000295	CcSEcCtD
Selegiline—Asthenia—Betamethasone—multiple sclerosis	7.65e-05	0.000295	CcSEcCtD
Selegiline—Asthenia—Dexamethasone—multiple sclerosis	7.65e-05	0.000295	CcSEcCtD
Selegiline—Nervous system disorder—Methotrexate—multiple sclerosis	7.61e-05	0.000293	CcSEcCtD
Selegiline—MAOA—nervous system—multiple sclerosis	7.61e-05	0.0198	CbGeAlD
Selegiline—CYP2E1—medulla oblongata—multiple sclerosis	7.61e-05	0.0198	CbGeAlD
Selegiline—Thrombocytopenia—Methotrexate—multiple sclerosis	7.6e-05	0.000293	CcSEcCtD
Selegiline—Gastrointestinal pain—Prednisone—multiple sclerosis	7.6e-05	0.000292	CcSEcCtD
Selegiline—Nausea—Prednisolone—multiple sclerosis	7.59e-05	0.000292	CcSEcCtD
Selegiline—Pruritus—Betamethasone—multiple sclerosis	7.55e-05	0.00029	CcSEcCtD
Selegiline—Pruritus—Dexamethasone—multiple sclerosis	7.55e-05	0.00029	CcSEcCtD
Selegiline—Skin disorder—Methotrexate—multiple sclerosis	7.54e-05	0.00029	CcSEcCtD
Selegiline—Hyperhidrosis—Methotrexate—multiple sclerosis	7.51e-05	0.000289	CcSEcCtD
Selegiline—Vomiting—Triamcinolone—multiple sclerosis	7.48e-05	0.000288	CcSEcCtD
Selegiline—Vomiting—Methylprednisolone—multiple sclerosis	7.46e-05	0.000287	CcSEcCtD
Selegiline—MAOB—Metabolism—GPC5—multiple sclerosis	7.45e-05	0.0015	CbGpPWpGaD
Selegiline—Rash—Triamcinolone—multiple sclerosis	7.41e-05	0.000285	CcSEcCtD
Selegiline—Dermatitis—Triamcinolone—multiple sclerosis	7.41e-05	0.000285	CcSEcCtD
Selegiline—Anorexia—Methotrexate—multiple sclerosis	7.4e-05	0.000285	CcSEcCtD
Selegiline—Rash—Methylprednisolone—multiple sclerosis	7.4e-05	0.000285	CcSEcCtD
Selegiline—Dermatitis—Methylprednisolone—multiple sclerosis	7.39e-05	0.000284	CcSEcCtD
Selegiline—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.39e-05	0.00149	CbGpPWpGaD
Selegiline—Urticaria—Prednisone—multiple sclerosis	7.38e-05	0.000284	CcSEcCtD
Selegiline—Headache—Triamcinolone—multiple sclerosis	7.37e-05	0.000283	CcSEcCtD
Selegiline—Headache—Methylprednisolone—multiple sclerosis	7.35e-05	0.000283	CcSEcCtD
Selegiline—Abdominal pain—Prednisone—multiple sclerosis	7.34e-05	0.000283	CcSEcCtD
Selegiline—Body temperature increased—Prednisone—multiple sclerosis	7.34e-05	0.000283	CcSEcCtD
Selegiline—ABCB1—Allograft Rejection—FAS—multiple sclerosis	7.34e-05	0.00148	CbGpPWpGaD
Selegiline—MAOA—central nervous system—multiple sclerosis	7.33e-05	0.0191	CbGeAlD
Selegiline—Diarrhoea—Dexamethasone—multiple sclerosis	7.3e-05	0.000281	CcSEcCtD
Selegiline—Diarrhoea—Betamethasone—multiple sclerosis	7.3e-05	0.000281	CcSEcCtD
Selegiline—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	7.3e-05	0.00147	CbGpPWpGaD
Selegiline—Hypotension—Methotrexate—multiple sclerosis	7.26e-05	0.000279	CcSEcCtD
Selegiline—MAOA—Metabolism—SRM—multiple sclerosis	7.25e-05	0.00146	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	7.21e-05	0.00145	CbGpPWpGaD
Selegiline—MAOA—cerebellum—multiple sclerosis	7.17e-05	0.0187	CbGeAlD
Selegiline—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	7.07e-05	0.000272	CcSEcCtD
Selegiline—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	7.07e-05	0.00142	CbGpPWpGaD
Selegiline—Dizziness—Betamethasone—multiple sclerosis	7.05e-05	0.000271	CcSEcCtD
Selegiline—Dizziness—Dexamethasone—multiple sclerosis	7.05e-05	0.000271	CcSEcCtD
Selegiline—Insomnia—Methotrexate—multiple sclerosis	7.02e-05	0.00027	CcSEcCtD
Selegiline—Nausea—Triamcinolone—multiple sclerosis	6.98e-05	0.000269	CcSEcCtD
Selegiline—Paraesthesia—Methotrexate—multiple sclerosis	6.97e-05	0.000268	CcSEcCtD
Selegiline—Nausea—Methylprednisolone—multiple sclerosis	6.97e-05	0.000268	CcSEcCtD
Selegiline—Dyspnoea—Methotrexate—multiple sclerosis	6.92e-05	0.000266	CcSEcCtD
Selegiline—Somnolence—Methotrexate—multiple sclerosis	6.9e-05	0.000266	CcSEcCtD
Selegiline—Hypersensitivity—Prednisone—multiple sclerosis	6.84e-05	0.000263	CcSEcCtD
Selegiline—Dyspepsia—Methotrexate—multiple sclerosis	6.83e-05	0.000263	CcSEcCtD
Selegiline—MAOB—brain—multiple sclerosis	6.82e-05	0.0178	CbGeAlD
Selegiline—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.79e-05	0.00137	CbGpPWpGaD
Selegiline—Vomiting—Betamethasone—multiple sclerosis	6.78e-05	0.000261	CcSEcCtD
Selegiline—Vomiting—Dexamethasone—multiple sclerosis	6.78e-05	0.000261	CcSEcCtD
Selegiline—CYP2E1—spinal cord—multiple sclerosis	6.78e-05	0.0177	CbGeAlD
Selegiline—Decreased appetite—Methotrexate—multiple sclerosis	6.75e-05	0.00026	CcSEcCtD
Selegiline—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.73e-05	0.00136	CbGpPWpGaD
Selegiline—Rash—Betamethasone—multiple sclerosis	6.73e-05	0.000259	CcSEcCtD
Selegiline—Rash—Dexamethasone—multiple sclerosis	6.73e-05	0.000259	CcSEcCtD
Selegiline—Dermatitis—Dexamethasone—multiple sclerosis	6.72e-05	0.000259	CcSEcCtD
Selegiline—Dermatitis—Betamethasone—multiple sclerosis	6.72e-05	0.000259	CcSEcCtD
Selegiline—MAOA—Biological oxidations—POMC—multiple sclerosis	6.72e-05	0.00135	CbGpPWpGaD
Selegiline—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.71e-05	0.00135	CbGpPWpGaD
Selegiline—Gastrointestinal disorder—Methotrexate—multiple sclerosis	6.7e-05	0.000258	CcSEcCtD
Selegiline—Fatigue—Methotrexate—multiple sclerosis	6.69e-05	0.000258	CcSEcCtD
Selegiline—Headache—Dexamethasone—multiple sclerosis	6.68e-05	0.000257	CcSEcCtD
Selegiline—Headache—Betamethasone—multiple sclerosis	6.68e-05	0.000257	CcSEcCtD
Selegiline—Asthenia—Prednisone—multiple sclerosis	6.67e-05	0.000256	CcSEcCtD
Selegiline—Pain—Methotrexate—multiple sclerosis	6.64e-05	0.000255	CcSEcCtD
Selegiline—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	6.59e-05	0.00133	CbGpPWpGaD
Selegiline—Pruritus—Prednisone—multiple sclerosis	6.57e-05	0.000253	CcSEcCtD
Selegiline—Feeling abnormal—Methotrexate—multiple sclerosis	6.4e-05	0.000246	CcSEcCtD
Selegiline—Diarrhoea—Prednisone—multiple sclerosis	6.36e-05	0.000245	CcSEcCtD
Selegiline—Gastrointestinal pain—Methotrexate—multiple sclerosis	6.35e-05	0.000244	CcSEcCtD
Selegiline—Nausea—Betamethasone—multiple sclerosis	6.34e-05	0.000244	CcSEcCtD
Selegiline—Nausea—Dexamethasone—multiple sclerosis	6.34e-05	0.000244	CcSEcCtD
Selegiline—MAOB—Metabolism—RRM1—multiple sclerosis	6.17e-05	0.00124	CbGpPWpGaD
Selegiline—Urticaria—Methotrexate—multiple sclerosis	6.17e-05	0.000237	CcSEcCtD
Selegiline—Dizziness—Prednisone—multiple sclerosis	6.14e-05	0.000236	CcSEcCtD
Selegiline—Body temperature increased—Methotrexate—multiple sclerosis	6.14e-05	0.000236	CcSEcCtD
Selegiline—Abdominal pain—Methotrexate—multiple sclerosis	6.14e-05	0.000236	CcSEcCtD
Selegiline—CYP2B6—nervous system—multiple sclerosis	6.09e-05	0.0159	CbGeAlD
Selegiline—ABCB1—Allograft Rejection—CD80—multiple sclerosis	6.09e-05	0.00123	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.08e-05	0.00122	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.08e-05	0.00122	CbGpPWpGaD
Selegiline—ABCB1—retina—multiple sclerosis	5.99e-05	0.0156	CbGeAlD
Selegiline—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.99e-05	0.0012	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	5.92e-05	0.00119	CbGpPWpGaD
Selegiline—Vomiting—Prednisone—multiple sclerosis	5.91e-05	0.000227	CcSEcCtD
Selegiline—CYP2B6—central nervous system—multiple sclerosis	5.86e-05	0.0153	CbGeAlD
Selegiline—Rash—Prednisone—multiple sclerosis	5.86e-05	0.000225	CcSEcCtD
Selegiline—Dermatitis—Prednisone—multiple sclerosis	5.85e-05	0.000225	CcSEcCtD
Selegiline—Headache—Prednisone—multiple sclerosis	5.82e-05	0.000224	CcSEcCtD
Selegiline—MAOA—brain—multiple sclerosis	5.82e-05	0.0152	CbGeAlD
Selegiline—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.76e-05	0.00116	CbGpPWpGaD
Selegiline—Hypersensitivity—Methotrexate—multiple sclerosis	5.72e-05	0.00022	CcSEcCtD
Selegiline—CYP2E1—nervous system—multiple sclerosis	5.71e-05	0.0149	CbGeAlD
Selegiline—CYP2A6—Metabolism—SRM—multiple sclerosis	5.63e-05	0.00113	CbGpPWpGaD
Selegiline—Asthenia—Methotrexate—multiple sclerosis	5.57e-05	0.000214	CcSEcCtD
Selegiline—Nausea—Prednisone—multiple sclerosis	5.52e-05	0.000212	CcSEcCtD
Selegiline—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.51e-05	0.00111	CbGpPWpGaD
Selegiline—CYP2E1—central nervous system—multiple sclerosis	5.5e-05	0.0143	CbGeAlD
Selegiline—Pruritus—Methotrexate—multiple sclerosis	5.49e-05	0.000211	CcSEcCtD
Selegiline—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.46e-05	0.0011	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.43e-05	0.00109	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.43e-05	0.00109	CbGpPWpGaD
Selegiline—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.42e-05	0.00109	CbGpPWpGaD
Selegiline—MAOA—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	5.39e-05	0.00108	CbGpPWpGaD
Selegiline—CYP2E1—cerebellum—multiple sclerosis	5.38e-05	0.014	CbGeAlD
Selegiline—Diarrhoea—Methotrexate—multiple sclerosis	5.31e-05	0.000204	CcSEcCtD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	5.28e-05	0.00106	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	5.27e-05	0.00106	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	5.26e-05	0.00106	CbGpPWpGaD
Selegiline—CYP2A6—Biological oxidations—POMC—multiple sclerosis	5.22e-05	0.00105	CbGpPWpGaD
Selegiline—CYP2C8—brain—multiple sclerosis	5.19e-05	0.0135	CbGeAlD
Selegiline—Dizziness—Methotrexate—multiple sclerosis	5.13e-05	0.000198	CcSEcCtD
Selegiline—MAOA—Metabolism—CYP27B1—multiple sclerosis	5.11e-05	0.00103	CbGpPWpGaD
Selegiline—MAOA—Metabolism—CYP24A1—multiple sclerosis	5.11e-05	0.00103	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.95e-05	0.000996	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.95e-05	0.000996	CbGpPWpGaD
Selegiline—Vomiting—Methotrexate—multiple sclerosis	4.94e-05	0.00019	CcSEcCtD
Selegiline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	4.9e-05	0.000986	CbGpPWpGaD
Selegiline—Rash—Methotrexate—multiple sclerosis	4.9e-05	0.000188	CcSEcCtD
Selegiline—Dermatitis—Methotrexate—multiple sclerosis	4.89e-05	0.000188	CcSEcCtD
Selegiline—Headache—Methotrexate—multiple sclerosis	4.86e-05	0.000187	CcSEcCtD
Selegiline—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	4.81e-05	0.000969	CbGpPWpGaD
Selegiline—MAOA—Metabolism—GPC5—multiple sclerosis	4.67e-05	0.00094	CbGpPWpGaD
Selegiline—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.67e-05	0.000939	CbGpPWpGaD
Selegiline—CYP2B6—brain—multiple sclerosis	4.65e-05	0.0121	CbGeAlD
Selegiline—Nausea—Methotrexate—multiple sclerosis	4.61e-05	0.000177	CcSEcCtD
Selegiline—CYP3A4—nervous system—multiple sclerosis	4.6e-05	0.012	CbGeAlD
Selegiline—CYP2B6—Metabolism—SRM—multiple sclerosis	4.54e-05	0.000914	CbGpPWpGaD
Selegiline—CYP2D6—nervous system—multiple sclerosis	4.52e-05	0.0118	CbGeAlD
Selegiline—CYP2E1—Metabolism—SRM—multiple sclerosis	4.45e-05	0.000895	CbGpPWpGaD
Selegiline—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.44e-05	0.000894	CbGpPWpGaD
Selegiline—CYP3A4—central nervous system—multiple sclerosis	4.43e-05	0.0115	CbGeAlD
Selegiline—CYP2E1—brain—multiple sclerosis	4.37e-05	0.0114	CbGeAlD
Selegiline—CYP2D6—central nervous system—multiple sclerosis	4.36e-05	0.0114	CbGeAlD
Selegiline—ABCB1—medulla oblongata—multiple sclerosis	4.33e-05	0.0113	CbGeAlD
Selegiline—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	4.29e-05	0.000864	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—IL2—multiple sclerosis	4.28e-05	0.000861	CbGpPWpGaD
Selegiline—CYP2D6—cerebellum—multiple sclerosis	4.26e-05	0.0111	CbGeAlD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	4.23e-05	0.000851	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.23e-05	0.000851	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.23e-05	0.000851	CbGpPWpGaD
Selegiline—CYP2B6—Biological oxidations—POMC—multiple sclerosis	4.21e-05	0.000847	CbGpPWpGaD
Selegiline—CYP2E1—Biological oxidations—POMC—multiple sclerosis	4.12e-05	0.00083	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	4.11e-05	0.000828	CbGpPWpGaD
Selegiline—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.11e-05	0.000827	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	4.1e-05	0.000826	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	4.03e-05	0.00081	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—CYP24A1—multiple sclerosis	3.97e-05	0.000798	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—CYP27B1—multiple sclerosis	3.97e-05	0.000798	CbGpPWpGaD
Selegiline—ABCB1—midbrain—multiple sclerosis	3.96e-05	0.0103	CbGeAlD
Selegiline—MAOA—SIDS Susceptibility Pathways—TNF—multiple sclerosis	3.91e-05	0.000787	CbGpPWpGaD
Selegiline—MAOA—Metabolism—RRM1—multiple sclerosis	3.87e-05	0.000779	CbGpPWpGaD
Selegiline—ABCB1—spinal cord—multiple sclerosis	3.86e-05	0.0101	CbGeAlD
Selegiline—CYP2C8—Metabolism—SRM—multiple sclerosis	3.85e-05	0.000774	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	3.83e-05	0.000771	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	3.83e-05	0.000771	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—GPC5—multiple sclerosis	3.63e-05	0.00073	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	3.62e-05	0.000729	CbGpPWpGaD
Selegiline—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.6e-05	0.000725	CbGpPWpGaD
Selegiline—CYP2C8—Biological oxidations—POMC—multiple sclerosis	3.56e-05	0.000717	CbGpPWpGaD
Selegiline—MAOB—Metabolism—BCHE—multiple sclerosis	3.54e-05	0.000713	CbGpPWpGaD
Selegiline—CYP2D6—brain—multiple sclerosis	3.46e-05	0.00902	CbGeAlD
Selegiline—CYP2C19—Metabolism—SRM—multiple sclerosis	3.43e-05	0.000691	CbGpPWpGaD
Selegiline—CYP2A6—NRF2 pathway—TGFB1—multiple sclerosis	3.43e-05	0.00069	CbGpPWpGaD
Selegiline—MAOA—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.37e-05	0.000678	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—SRM—multiple sclerosis	3.35e-05	0.000674	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	3.34e-05	0.000671	CbGpPWpGaD
Selegiline—ABCB1—nervous system—multiple sclerosis	3.25e-05	0.00848	CbGeAlD
Selegiline—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.25e-05	0.000653	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	3.2e-05	0.000644	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	3.2e-05	0.000644	CbGpPWpGaD
Selegiline—CYP2C19—Biological oxidations—POMC—multiple sclerosis	3.18e-05	0.00064	CbGpPWpGaD
Selegiline—MAOA—SIDS Susceptibility Pathways—IL6—multiple sclerosis	3.16e-05	0.000635	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—SRM—multiple sclerosis	3.16e-05	0.000635	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	3.13e-05	0.000631	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	3.13e-05	0.000631	CbGpPWpGaD
Selegiline—ABCB1—central nervous system—multiple sclerosis	3.13e-05	0.00817	CbGeAlD
Selegiline—CYP2C9—Metabolism—SRM—multiple sclerosis	3.13e-05	0.00063	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—TNF—multiple sclerosis	3.12e-05	0.000627	CbGpPWpGaD
Selegiline—ABCB1—cerebellum—multiple sclerosis	3.06e-05	0.00798	CbGeAlD
Selegiline—CYP2A6—Metabolism—RRM1—multiple sclerosis	3.01e-05	0.000605	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—GPC5—multiple sclerosis	2.93e-05	0.000589	CbGpPWpGaD
Selegiline—CYP2D6—Biological oxidations—POMC—multiple sclerosis	2.93e-05	0.000589	CbGpPWpGaD
Selegiline—CYP2C9—Biological oxidations—POMC—multiple sclerosis	2.9e-05	0.000584	CbGpPWpGaD
Selegiline—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.87e-05	0.000578	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—GPC5—multiple sclerosis	2.87e-05	0.000577	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	2.71e-05	0.000545	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	2.71e-05	0.000545	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—SRM—multiple sclerosis	2.67e-05	0.000538	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.65e-05	0.000533	CbGpPWpGaD
Selegiline—MAOA—Neuronal System—MAPK1—multiple sclerosis	2.58e-05	0.000519	CbGpPWpGaD
Selegiline—ABCB1—brain—multiple sclerosis	2.49e-05	0.00649	CbGeAlD
Selegiline—CYP1A2—Biological oxidations—POMC—multiple sclerosis	2.48e-05	0.000499	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—GPC5—multiple sclerosis	2.48e-05	0.000499	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—RRM1—multiple sclerosis	2.43e-05	0.000488	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	2.42e-05	0.000487	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	2.42e-05	0.000487	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—RRM1—multiple sclerosis	2.38e-05	0.000478	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.36e-05	0.000476	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CYP27B1—multiple sclerosis	2.36e-05	0.000475	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.36e-05	0.000475	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	2.22e-05	0.000448	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	2.22e-05	0.000448	CbGpPWpGaD
Selegiline—MAOA—Metabolism—BCHE—multiple sclerosis	2.22e-05	0.000447	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.21e-05	0.000445	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.2e-05	0.000444	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.2e-05	0.000444	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—GPC5—multiple sclerosis	2.16e-05	0.000434	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.15e-05	0.000434	CbGpPWpGaD
Selegiline—MAOB—Metabolism—APOE—multiple sclerosis	2.13e-05	0.000429	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—SRM—multiple sclerosis	2.06e-05	0.000415	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—RRM1—multiple sclerosis	2.05e-05	0.000413	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—GPC5—multiple sclerosis	2.03e-05	0.000409	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.02e-05	0.000406	CbGpPWpGaD
Selegiline—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.91e-05	0.000385	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.88e-05	0.000379	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.88e-05	0.000379	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.84e-05	0.000371	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.83e-05	0.000369	CbGpPWpGaD
Selegiline—MAOB—Metabolism—POMC—multiple sclerosis	1.83e-05	0.000369	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—RRM1—multiple sclerosis	1.79e-05	0.00036	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—BCHE—multiple sclerosis	1.73e-05	0.000347	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.72e-05	0.000347	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.69e-05	0.000339	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.67e-05	0.000336	CbGpPWpGaD
Selegiline—MAOB—Metabolism—ALB—multiple sclerosis	1.67e-05	0.000336	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.65e-05	0.000332	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.65e-05	0.000331	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.61e-05	0.000325	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.59e-05	0.000321	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.54e-05	0.000309	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.45e-05	0.000293	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.45e-05	0.000293	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.43e-05	0.000287	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.42e-05	0.000286	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—BCHE—multiple sclerosis	1.39e-05	0.00028	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.37e-05	0.000275	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—BCHE—multiple sclerosis	1.36e-05	0.000275	CbGpPWpGaD
Selegiline—MAOA—Metabolism—APOE—multiple sclerosis	1.34e-05	0.000269	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.33e-05	0.000268	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.3e-05	0.000261	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.25e-05	0.000251	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.22e-05	0.000246	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.18e-05	0.000237	CbGpPWpGaD
Selegiline—MAOA—Metabolism—POMC—multiple sclerosis	1.15e-05	0.000231	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.11e-05	0.000224	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.11e-05	0.000224	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.11e-05	0.000223	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.1e-05	0.000222	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.05e-05	0.000212	CbGpPWpGaD
Selegiline—MAOA—Metabolism—ALB—multiple sclerosis	1.05e-05	0.000211	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—APOE—multiple sclerosis	1.04e-05	0.000209	CbGpPWpGaD
Selegiline—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.03e-05	0.000208	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—BCHE—multiple sclerosis	1.03e-05	0.000207	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.02e-05	0.000204	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—BCHE—multiple sclerosis	9.68e-06	0.000195	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—BCHE—multiple sclerosis	9.6e-06	0.000193	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.52e-06	0.000192	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—POMC—multiple sclerosis	8.92e-06	0.00018	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.68e-06	0.000175	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—APOE—multiple sclerosis	8.38e-06	0.000169	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—APOE—multiple sclerosis	8.21e-06	0.000165	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—BCHE—multiple sclerosis	8.2e-06	0.000165	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—ALB—multiple sclerosis	8.13e-06	0.000164	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—POMC—multiple sclerosis	7.2e-06	0.000145	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—APOE—multiple sclerosis	7.09e-06	0.000143	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—POMC—multiple sclerosis	7.05e-06	0.000142	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—ALB—multiple sclerosis	6.56e-06	0.000132	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—ALB—multiple sclerosis	6.43e-06	0.000129	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—APOE—multiple sclerosis	6.33e-06	0.000127	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—BCHE—multiple sclerosis	6.33e-06	0.000127	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—APOE—multiple sclerosis	6.18e-06	0.000124	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—POMC—multiple sclerosis	6.09e-06	0.000123	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—APOE—multiple sclerosis	5.82e-06	0.000117	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—APOE—multiple sclerosis	5.77e-06	0.000116	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—ALB—multiple sclerosis	5.56e-06	0.000112	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—POMC—multiple sclerosis	5.44e-06	0.000109	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—POMC—multiple sclerosis	5.31e-06	0.000107	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—POMC—multiple sclerosis	5e-06	0.000101	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—POMC—multiple sclerosis	4.96e-06	9.98e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—ALB—multiple sclerosis	4.96e-06	9.98e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—APOE—multiple sclerosis	4.93e-06	9.93e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—ALB—multiple sclerosis	4.84e-06	9.74e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—ALB—multiple sclerosis	4.56e-06	9.18e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—ALB—multiple sclerosis	4.52e-06	9.1e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—POMC—multiple sclerosis	4.24e-06	8.53e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ALB—multiple sclerosis	3.86e-06	7.78e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—APOE—multiple sclerosis	3.81e-06	7.66e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—POMC—multiple sclerosis	3.27e-06	6.58e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ALB—multiple sclerosis	2.98e-06	6e-05	CbGpPWpGaD
